SCHEMBL6895437

SCHEMBL6895437

CC(C)(C)N(C(=O)O)[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 17/20 0.34
CTSD P07339 15/20 0.34
ADRB1 P08588 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
MAOB P27338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5377720 0.87 BACE1 (0.34) BACE1CTSDADRB1MAOB
SCHEMBL5930180 0.82 HPGD (0.39)
SCHEMBL5930175 0.82 HPGD (0.39)
SCHEMBL5369028 0.81 BACE1 (0.40) BACE1CTSD
SCHEMBL5447147 0.80 BACE1 (0.38) BACE1CTSD
SCHEMBL5381670 0.77 BACE1 (0.49) BACE1CTSD
SCHEMBL5387700 0.77 BACE1 (0.52) BACE1CTSDADRB1
SCHEMBL5389034 0.77 BACE1 (0.49) BACE1CTSD
SCHEMBL5387696 0.77 BACE1 (0.52) BACE1CTSDADRB1
SCHEMBL14860346 0.75 MAOB (0.33) BACE1CTSDMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed